NCT04637009 2024-08-02A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid NeoplasmsAstex Pharmaceuticals, Inc.Phase 1 Terminated20 enrolled
NCT02125318 2017-02-27A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow DisordersGalena Biopharma, Inc.Phase 2 Completed18 enrolled